Sort by 'likes'
Targeting Stem Cells in Multiple Myeloma for Improved Outcomes
Multiple myeloma remains incurable despite improved remissions with novel agents. Relapse eventually occurs in the form of drug-resistant disease that carries a dismal prognosis. Relapse is dependent on stem cell functions. We are talking to Dr. William Matsui of Johns…
Bridging the Gap in Multiple Myeloma Survival
What is the gap in myeloma survival? Currently the National Cancer Institute reports a life expectancy of just over five years, whereas, myeloma specialists at myeloma centers of excellence have reported a life expectancy of over ten years for myeloma…
Demystifying Palliative Care (Supportive Care)
Palliative care is often confused with hospice. Very few people are aware that palliative care deals with the quality of life of patients who have a life threatening disease. This would include psychological, social problems in addition to preventing or…
Inherited Gene Mutations in Myeloma and Role of Precision Medicine
Multiple Myeloma is the second most common cancer of the blood and is largely incurable. A recent study has found that a specific gene mutation can increase the risk of developing myeloma six to nine fold. The lead author of…
Stem Cell Therapy for COVID-19 related ARDS (Acute Respiratory Distress Syndrome)
Acute respiratory distress syndrome or ARDS is a very serious complication for many patients suffering from COVID-19, and is believed to account for about 80% of the deaths in ventilated patients. There is no proven or FDA-approved treatment for it,…